1. Home
  2. MBIO vs CELZ Comparison

MBIO vs CELZ Comparison

Compare MBIO & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • CELZ
  • Stock Information
  • Founded
  • MBIO 2015
  • CELZ 1998
  • Country
  • MBIO United States
  • CELZ United States
  • Employees
  • MBIO N/A
  • CELZ N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • CELZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBIO Health Care
  • CELZ Health Care
  • Exchange
  • MBIO Nasdaq
  • CELZ Nasdaq
  • Market Cap
  • MBIO 4.7M
  • CELZ 5.5M
  • IPO Year
  • MBIO N/A
  • CELZ N/A
  • Fundamental
  • Price
  • MBIO $1.02
  • CELZ $2.68
  • Analyst Decision
  • MBIO
  • CELZ
  • Analyst Count
  • MBIO 0
  • CELZ 0
  • Target Price
  • MBIO N/A
  • CELZ N/A
  • AVG Volume (30 Days)
  • MBIO 87.6K
  • CELZ 84.5K
  • Earning Date
  • MBIO 08-12-2025
  • CELZ 08-08-2025
  • Dividend Yield
  • MBIO N/A
  • CELZ N/A
  • EPS Growth
  • MBIO N/A
  • CELZ N/A
  • EPS
  • MBIO N/A
  • CELZ N/A
  • Revenue
  • MBIO N/A
  • CELZ $14,000.00
  • Revenue This Year
  • MBIO N/A
  • CELZ N/A
  • Revenue Next Year
  • MBIO N/A
  • CELZ N/A
  • P/E Ratio
  • MBIO N/A
  • CELZ N/A
  • Revenue Growth
  • MBIO N/A
  • CELZ 55.56
  • 52 Week Low
  • MBIO $1.01
  • CELZ $1.69
  • 52 Week High
  • MBIO $31.00
  • CELZ $6.90
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 35.22
  • CELZ 71.60
  • Support Level
  • MBIO $1.01
  • CELZ $2.36
  • Resistance Level
  • MBIO $1.10
  • CELZ $2.89
  • Average True Range (ATR)
  • MBIO 0.07
  • CELZ 0.24
  • MACD
  • MBIO -0.02
  • CELZ 0.05
  • Stochastic Oscillator
  • MBIO 3.45
  • CELZ 87.80

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About CELZ Creative Medical Technology Holdings Inc.

Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Share on Social Networks: